Jill S. Waibel, MD, FAAD
SESSIONS
DISCLOSURES
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);